Log InCreate an Account
  • Home
  • Contact us
  • SCAI.org Home |
  • SecondsCount.org |
  • eLearning Library |
  • Contribute to SCAI PAC |
  • my.scai.org
  • My SCAI
  • My Community
  • Member Directory
 Menu
  • Overview
  • Case Studies
  • Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 6.4b: Management of Cardiogenic Shock in STEMI - *Updated Version*

    Jeffrey J. Popma, MD - Director of Interventional Cardiology Clinical Services / Beth Israel Deaconess Medical Center / Boston, MA

    Duration: 1 hour

    Faculty Disclosure

    • Boston Scientific (Grants or Research Support)
    • Abbott Vascular (Consultant)
    • Abbott Vascular (Grants or Research Support)
    • Medtronic (Grants or Research Support)
    • Boston Scientific (Consultant)
    • Cook (Grants or Research Support)
    • Covidien (Consultant)
    • Cordis (Grants or Research Support)
    • Covidien (Grants or Research Support)

    Learning Objectives

    • To discuss the incidence and pathogenesis of patients who develop cardiogenic shock
    • To review the definitions of cardiogenic shock and outline the differential diagnosis in these patients
    • To understand the treatment options and prognosis in patients with cardiogenic shock
* Required
* First Name:
* Last Name:
Member ID:
* Phone Number:
* Email:
* Enter code:
* Message:
 

Thank you

Your feedback has been sent.